4.7 Article

The mouse Runx1+23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters

期刊

BLOOD
卷 113, 期 21, 页码 5121-5124

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-12-193003

关键词

-

资金

  1. Medical Research Council
  2. Leukemia Research Fund, United Kingdom
  3. MRC [MC_U137970202, G0800784] Funding Source: UKRI
  4. Medical Research Council [MC_U137970202, G0800784B, G0800784] Funding Source: researchfish

向作者/读者索取更多资源

The transcription factor Runx1 plays a pivotal role in hematopoietic stem cell (HSC) emergence, and studies into its transcriptional regulation should give insight into the critical steps of HSC specification. Recently, we identified the Runx1 + 23 enhancer that targets reporter gene expression to the first emerging HSCs of the mouse embryo when linked to the heterologous hsp68 promoter. Endogenous Runx1 is transcribed from 2 alternative promoters, P1 and P2. Here, we examined the in vivo cis-regulatory potential of these alternative promoters and asked whether they act with and contribute to the spatiotemporal specific expression of the Runx1 + 23 enhancer. Our results firmly establish that, in contrast to zebrafish runx1, mouse Runx1 promoter sequences do not confer any hematopoietic specificity in transgenic embryos. Yet, both mouse promoters act with the + 23 enhancer to drive reporter gene expression to sites of HSC emergence and colonization, in a + 23-specific pattern. (Blood. 2009; 113: 5121-5124)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据